Author Correction: FcRH5×CD3 bispecific antibody cevostamab in relapsed or refractory multiple myeloma: a phase 1 trial.

Authors

Adam D Cohen, Joshua Richter, Suzanne Trudel, Alexander Lesokhin, Jacob P Laubach, Sheeba K Thomas, Simon J Harrison, Luciano J Costa, Andrew Spencer, Rafael Fonseca, Peter A Forsberg, Jesus G Berdeja, Rayan Kaedbey, Nizar J Bahlis, Paula Rodriguez-Otero, Maria-Victoria Mateos, Tulika Tyagi, Divya Samineni, Wenyu Liu, Rin Nakamura, Voleak Choeurng, Chihunt Wong, James Cooper, Amrita Krishnan

Published in

Nature medicine. Oct 20, 2026. Epub Oct 20, 2026.

PMID:
42901991
Bibliographic data and abstract were imported from PubMed on 21 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.